Efficacy and safety of intensive downstaging polypectomy (IDP) for multiple duodenal adenomas in patients with familial adenomatous polyposis: a prospective cohort study
Endoscopy · 2023-06 · 55 (06) · 515-523
DOI: 10.1055/a-1983-5963 ↗Kurz gefasst
Klinische Studie (Phase II) in der Zeitschrift Endoscopy, online erschienen am 22.02.2023. Verfasst von Yoji Takeuchi und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka, Japan. Hauptthemen laut MEDLINE: Colonic Polyps, Adenomatous Polyposis Coli. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Background
Patients with familial adenomatous polyposis (FAP) risk developing multiple duodenal adenomas (MDAs), leading to duodenal cancer and death. We investigated the efficacy and safety of intensive downstaging polypectomy (IDP) for MDAs integrated with new-generation procedures.
Methods
This prospective phase II study, conducted at a tertiary cancer center, enrolled patients with FAP who had MDAs. We performed IDP including cold snare/forceps polypectomy (CSP/CFP) and underwater endoscopic mucosal resection (UEMR). The primary end point was the downstaging of Spigelman stage at 1-year follow-up.
Results
2424 duodenal polyps in 58 patients with FAP underwent IDP, including 2413 CSPs in 57 patients, seven CFPs in one patient, and four UEMRs in four patients. Only one major adverse event was observed (grade 3 hyperamylasemia) without clinical manifestations. We performed additional UEMR, CSP, and CFP for one, 12, and 22 patients, respectively, during initial follow-up. Overall, 55 patients completed protocol examination; the Spigelman stage was significantly reduced at the 1-year follow-up endoscopy (P < 0.001), with downstaging observed in 39 patients (71 %). Among the 26 patients with Spigelman stage IV at initial examination and protocol completion, 23 (88 %) showed downstaging. There was no major change in Spigelman stages from 1-year follow-up esophagogastroduodenoscopy to a median of 37 months (range 3–56).
Conclusions
IDP, including new-generation procedures, showed significant downstaging with acceptable adverse events for MDA in patients with FAP, even those with advanced-stage disease. Lesion selection for different resection techniques may be important for suitable and sustainable management of MDA in patients with FAP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Gastrointestinal Oncology, Osaka International Cancer Institute, Osaka, Japan.
- Department of Genetic Oncology, Division of Hereditary Tumors, Osaka International Cancer Institute, Osaka, Japan.
- Department of Practical Gastrointestinal Endoscopy, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
- Department of Gastroenterology, Japan Community Health Care Organization Hoshigaoka Medical Center, Osaka, Japan.
- Division of Gastroenterology, Department of Internal Medicine, Graduate School of Medicine, Kobe University, Kobe, Japan.
- Department of Gastroenterology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
ORCID-Profile: Yoji Takeuchi, Kenta Hamada, Yasuhiro Tani, Satoki Shichijo, Takashi Kanesaka, Noriya Uedo
Förderung
- Japan Agency for Medical Research and Development
Zitieren
APA
Takeuchi, Y., Hamada, K., Nakahira, H., Shimamoto, Y., Sakurai, H., Tani, Y., Shichijo, S., Maekawa, A., Kanesaka, T., Yamamoto, S., Higashino, K., Fujisawa, F., Ezoe, Y., Ishikawa, H., Mutoh, M., Uedo, N., Nojima, M., & Ishihara, R. (2023). Efficacy and safety of intensive downstaging polypectomy (IDP) for multiple duodenal adenomas in patients with familial adenomatous polyposis: a prospective cohort study. Endoscopy, 55(06), 515-523. https://doi.org/10.1055/a-1983-5963
Vancouver
Takeuchi Y, Hamada K, Nakahira H, Shimamoto Y, Sakurai H, Tani Y, et al. Efficacy and safety of intensive downstaging polypectomy (IDP) for multiple duodenal adenomas in patients with familial adenomatous polyposis: a prospective cohort study. Endoscopy. 2023;55(06):515-523. doi:10.1055/a-1983-5963
BibTeX
@article{Takeuchi2023,
author = {Takeuchi, Yoji and Hamada, Kenta and Nakahira, Hiroko and Shimamoto, Yusaku and Sakurai, Hirohisa and Tani, Yasuhiro and Shichijo, Satoki and Maekawa, Akira and Kanesaka, Takashi and Yamamoto, Sachiko and Higashino, Koji and Fujisawa, Fumie and Ezoe, Yasumasa and Ishikawa, Hideki and Mutoh, Michihiro and Uedo, Noriya and Nojima, Masanori and Ishihara, Ryu},
title = {Efficacy and safety of intensive downstaging polypectomy (IDP) for multiple duodenal adenomas in patients with familial adenomatous polyposis: a prospective cohort study},
journal = {Endoscopy},
year = {2023},
volume = {55},
number = {06},
pages = {515--523},
doi = {10.1055/a-1983-5963}
}
EUVIMED